Croda International (LON:CRDA - Get Free Report)'s stock had its "buy" rating reissued by equities researchers at Jefferies Financial Group in a research note issued on Wednesday,Digital Look reports. They presently have a GBX 3,500 price target on the stock. Jefferies Financial Group's price target indicates a potential upside of 9.24% from the stock's current price.
CRDA has been the topic of several other reports. Citigroup upped their target price on Croda International from GBX 3,050 to GBX 3,200 and gave the stock a "neutral" rating in a research report on Wednesday. Berenberg Bank reissued a "buy" rating and issued a GBX 3,600 price target on shares of Croda International in a research note on Wednesday. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of GBX 3,390.
Get Our Latest Stock Analysis on CRDA
Croda International Price Performance
CRDA opened at GBX 3,204 on Wednesday. The stock has a market cap of £4.46 billion, a price-to-earnings ratio of 72.16, a PEG ratio of 1.40 and a beta of 0.92. Croda International has a 1 year low of GBX 2,426.77 and a 1 year high of GBX 3,312. The company has a current ratio of 1.99, a quick ratio of 2.25 and a debt-to-equity ratio of 31.85. The stock has a fifty day moving average price of GBX 2,989.04 and a 200 day moving average price of GBX 2,900.62.
Insiders Place Their Bets
In other Croda International news, insider Steve Foots sold 73 shares of the company's stock in a transaction that occurred on Tuesday, May 5th. The stock was sold at an average price of GBX 2,840, for a total transaction of £2,073.20. In the last three months, insiders purchased 25 shares of company stock valued at $72,490. 0.83% of the stock is currently owned by insiders.
Croda International Company Profile
(
Get Free Report)
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Croda International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Croda International wasn't on the list.
While Croda International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.